Company: IMCR
Filing Date: 2025-03-17
Form Type: 424B7
Source: 0001140361-25-008917
Chunk: 44

Company: Immunocore Holdings plc
Filing Date: 2025-03-17
Form: 424B7
Chunk 44
---
 are not listed for trading on a U.S. national or regional securities exchange on the relevant date, the “last reported sale price” will be the last quoted bid price for our ADSs (or such other security) in the over-the-counter market on the relevant date as reported by OTC Markets Group Inc. or a similar organization. If our ADSs (or such other security) are not so quoted, the “last reported sale price” will be the average of the mid-point of the last bid and ask prices for our ADSs (or such other security) on the relevant date from each of at least three nationally recognized independent investment banking firms selected by us for this purpose. The “last reported sale price” will be determined without regard to after hours trading or any other trading outside of regular trading session hours.

Except for purposes of determining any cash amounts due pursuant to “—Conversion Rights—Conversion Share Limitations,” “trading day” means a day on which (i) trading in our ADSs (or other security for which a closing sale price must be determined) generally occurs on the Nasdaq Global Select Market or, if our ADSs (or such other security) are not then listed on the Nasdaq Global Select Market, on the principal other U.S. national or regional securities exchange on which our ADSs (or such other security) are then listed or, if our ADSs (or such other security) are not then listed on a U.S. national or regional securities exchange, on the principal other market on which our ADSs (or such other security) are then traded, and (ii) a last reported sale price for our ADSs (or closing sale price for such other security) is available on such securities exchange or market. If our ADSs (or such other security) is not so listed or traded, “trading day” means a “business day.”

#### Additional Amounts
All payments made in cash by, or on behalf of, us or any successor to us under or with respect to the notes, of principal (including, if applicable, the optional redemption price, the tax redemption price and the fundamental change repurchase price) and interest (including any additional interest), but excluding payments in cash in lieu of delivery of ADSs as described under the caption “—Conversion Rights—Conversion Share Limitations” and deliveries of ADSs (or the ordinary shares represented thereby) or other reference property or any other consideration due upon conversion (together with payments of cash for any fractional ADS) (